UPDATE
-
New Finding Published on Ebiomedicine 2018-02-23
Recently, the new research finding of the China-US(Henan)Hormel Cancer Institute, Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization, was published on EBioMedicine, a well-known journal on translational medicine, co-launched by two world class academic journals, …
-
On August 22, 2017, a mid-term review of the research and application project for high-precision cancer prevention and control of Henan Province, a major scientific and technological project in Henan Province, was held in China-US (Henan) Hormel Cancer Institute. Director of Foreign Science and Technology Cooperati…
-
The People's Republic of China ministry of science and technology, division head of the international cooperation Jia Le, the section chief of the science and technology department inspected the China-US (Henan) Hormel Cancer Institute.During the discussion, Vice President Kangdong Liu reported on the background…
-
On March 24th, 2017, Reuben Harris, University of Minnesota Department of Biochemistry, Molecular Biology & Biophysics, visted China-US(Henan) hormel cancer institute for academic exchange and gave a lecture entitled “Clinical Impact and Molecular Mechanism of APOBEC Mutagenesis in Breast Cancer”. and then had de…
-
On March 23rd. This journal was founded by China-US (Henan) Hormel Cancer Institute, Hormel Institute (American) and Nature. The journal is committed to publishing advanced scientific research in all fields of tumor precision medicine, basic research designing, application transforming and clinical study.Dr. Ann Bo…
-
The Academician Hongyang Wang Recruited as an Respecially-Appointed Professor of Our Institute 2017-03-18
A special Professor Appointment ceremony was held in China-US (Henan) Hormel Cancer Institute In March 18th. Dr. Hongyang Wang was employed as a special professor in our institute, she will work with experts in Henan province and contributes to the basic and clinical Research of transformation medicine and precise …
-
Chen Zhu’s Visit to Our Institute 2017-01-02
On the afternoon of January 10, after the Summit Forum on Healthy Central China, Chen Zhu, vice chairman of the standing committee of the NPC & chairman of the central committee of the Chinese Peasants’ and Workers’ Democratic Party(CPWDP), inspected the China-US (Henan) Hormel Cancer Institute, together with other…
-
Prof. Yong Sang Song's “Study on Malignant Ascites of Ovarian Cancer from Molecular Level to Clinical Significance” introduces the important influence of malignant ascites of ovarian cancer on the tumor microenvironment. The study found that IL-6 levels in the malignant ascites of ovarian cancer are high, IL …
